Literature DB >> 8283041

Kinetics and specificity of peptide-MHC class II complex displacement reactions.

A I de Kroon1, H M McConnell.   

Abstract

The peptide-induced acceleration of the dissociation of pre-formed complexes of the detergent-solubilized mouse class II molecules IEd and IEk with fluorescein-labeled peptides was investigated using high-performance size exclusion chromatography. While it is generally believed that functional complexes of MHC class II alpha beta heterodimers and peptides have a 1:1 stoichiometry, the data provide qualitative as well as quantitative kinetic evidence that the enhancement of the release of one peptide by a second peptide is due to a two-peptide intermediate. Different combinations of peptides were tested for their ability to accelerate each other's release from IEd. The importance of positive charge for the interaction with IEd was confirmed by the finding that not only dynorphin 1-13 but also poly-L-lysine (14-19 mer) and a peptide corresponding to a mitochondrial presequence (net charge +6) efficiently enhance the release of pre-bound peptides. SDS-PAGE analysis revealed that the efficiently displacing peptides do not stabilize the IEd alpha beta heterodimer at acidic pH, in contrast to the IEd-restricted antigenic peptide HEL 107-116. The data support a mechanism in which the second peptide binds specifically to the pre-formed class II-peptide complex, which, depending on the properties of the peptides involved, leads to the destabilization of the complex and the release of the first peptide.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8283041

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Interpretation of biphasic dissociation kinetics for isomeric class II major histocompatibility complex-peptide complexes.

Authors:  T G Anderson; H M McConnell
Journal:  Biophys J       Date:  1999-11       Impact factor: 4.033

2.  Catalysis of peptide dissociation from class II MHC-peptide complexes.

Authors:  L Schmitt; J R Kratz; M M Davis; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

Review 3.  HLA-DM: arbiter conformationis.

Authors:  Andrea Ferrante
Journal:  Immunology       Date:  2013-02       Impact factor: 7.397

4.  Kinetic intermediates in the reactions between peptides and proteins of major histocompatibility complex class II.

Authors:  C Beeson; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

5.  The utility and limitations of current Web-available algorithms to predict peptides recognized by CD4 T cells in response to pathogen infection.

Authors:  Francisco A Chaves; Alvin H Lee; Jennifer L Nayak; Katherine A Richards; Andrea J Sant
Journal:  J Immunol       Date:  2012-03-30       Impact factor: 5.422

6.  H2E-derived Ealpha52-68 peptide presented by H2Ab interferes with clonal deletion of autoreactive T cells in autoimmune thyroiditis.

Authors:  Nicholas K Brown; Daniel J McCormick; Chella S David; Yi-chi M Kong
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

Review 7.  Measurement of Peptide Binding to MHC Class II Molecules by Fluorescence Polarization.

Authors:  Liusong Yin; Lawrence J Stern
Journal:  Curr Protoc Immunol       Date:  2014-08-01

8.  A structural transition in class II major histocompatibility complex proteins at mildly acidic pH.

Authors:  H A Runnels; J C Moore; P E Jensen
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

9.  A Peptide/MHCII conformer generated in the presence of exchange peptide is substrate for HLA-DM editing.

Authors:  Andrea Ferrante; Jack Gorski
Journal:  Sci Rep       Date:  2012-04-27       Impact factor: 4.379

Review 10.  Partnering for the major histocompatibility complex class II and antigenic determinant requires flexibility and chaperons.

Authors:  Scheherazade Sadegh-Nasseri
Journal:  Curr Opin Immunol       Date:  2021-06-17       Impact factor: 7.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.